Total Funding
87
54
Total FundingGrant raised
Growth Score 87 in past quarter
-5 pts
Heat Score 54 in past quarter
-25 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
86305
LifeGlue Technologies is a Finnish spin-out from Tampere University advancing Glue4Life.
- Paula Puistola: COO & Founder
- Laura Kuittinen: CEO & FounderPast Role: InvestorEye, Co-founder & ceo
About the Company
LifeGlue Technologies is a Finnish spin-out from Tampere University advancing Glue4Life, a clinical-grade hyaluronic-acid bioink/hydrogel engineered for translational use. Rooted in rigorous, peer-reviewed science, Glue4Life enables high-fidelity 3D bioprinting of human tissues and organs and is designed to support clinical pathways for
implantable constructs and advanced therapies. The platform’s reproducibility and ISO 13485/GMP-aligned documentation help ATMP developers move from R&D to manufacturing with fewer CMC risks. LifeGlue owns its core IP, has achieved first sales and active pilots, and partners with OEMs and leading labs to standardize the raw materials underpinning next-generation regenerative medicine.